The European Union's pharmaceutical sector is in a perpetual state of transformation. With stringent regulations, expanding patient demands, and the accelerated pace of development, navigating this complex landscape requires a strategic approach. Pharmaceutical companies must adjust to this changes by integrating innovative technologies, partnering